Geneos Wealth Management’s Labcorp LH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $147K | Sell |
550
-27
| -5% | -$7.31K | ﹤0.01% | 1062 |
|
|
2025
Q4 | $145K | Buy |
577
+347
| +151% | +$92.2K | ﹤0.01% | 1041 |
|
|
2025
Q3 | $66K | Sell |
230
-56
| -20% | -$15K | ﹤0.01% | 1275 |
|
|
2025
Q2 | $75.1K | Sell |
286
-60
| -17% | -$14.6K | ﹤0.01% | 1376 |
|
|
2025
Q1 | $104K | Buy |
346
+178
| +106% | +$43.2K | ﹤0.01% | 1552 |
|
|
2024
Q4 | $38.5K | Buy |
168
+127
| +310% | +$29.1K | ﹤0.01% | 1421 |
|
|
2024
Q3 | $9.16K | Buy |
+41
| New | +$9.01K | ﹤0.01% | 1873 |
|
|
2024
Q2 | – | Sell |
-150
| Closed | -$32.8K | – | 2131 |
|
|
2024
Q1 | $32.8K | Buy |
150
+9
| +6% | +$1.98K | ﹤0.01% | 1216 |
|
|
2023
Q4 | $32K | Sell |
141
-438
| -76% | -$92K | ﹤0.01% | 1211 |
|
|
2023
Q3 | $116K | Sell |
579
-67
| -10% | -$14.1K | 0.01% | 829 |
|
|
2023
Q2 | $134K | Hold |
646
| – | – | 0.01% | 790 |
|
|
2023
Q1 | $127K | Sell |
646
-233
| -27% | -$47.9K | 0.01% | 773 |
|
|
2022
Q4 | $178K | Hold |
879
| – | – | 0.01% | 660 |
|
|
2022
Q3 | $154K | Hold |
879
| – | – | 0.01% | 676 |
|
|
2022
Q2 | $181K | Sell |
879
-164
| -16% | -$35K | 0.01% | 780 |
|
|
2022
Q1 | $236K | Sell |
1,043
-6
| -0.6% | -$1.41K | 0.01% | 739 |
|
|
2021
Q4 | $283K | Buy |
1,049
+124
| +13% | +$30.7K | 0.01% | 746 |
|
|
2021
Q3 | $222K | Buy |
925
+1
| +0.1% | +$252 | 0.01% | 814 |
|
|
2021
Q2 | $220K | Sell |
924
-1,920
| -68% | -$437K | 0.01% | 805 |
|
|
2021
Q1 | $649K | Sell |
2,844
-94
| -3% | -$18.9K | 0.02% | 566 |
|
|
2020
Q4 | $208K | Buy |
2,938
+1,909
| +186% | +$330K | 0.01% | 812 |
|
|
2020
Q3 | $159K | Hold |
1,029
| – | – | 0.01% | 767 |
|
|
2020
Q2 | $143K | Buy |
1,029
+306
| +42% | +$42.3K | 0.01% | 773 |
|
|
2020
Q1 | $79K | Hold |
723
| – | – | 0.01% | 926 |
|
|
2019
Q4 | $105K | Sell |
723
-124
| -15% | -$17.9K | 0.01% | 932 |
|
|
2019
Q3 | $120K | Buy |
847
+371
| +78% | +$54.1K | 0.01% | 831 |
|
|
2019
Q2 | $70K | Sell |
476
-118
| -20% | -$16.5K | ﹤0.01% | 1039 |
|
|
2019
Q1 | $78K | Buy |
594
+70
| +13% | +$8.62K | 0.01% | 957 |
|
|
2018
Q4 | $56K | Sell |
524
-152
| -22% | -$20.4K | ﹤0.01% | 1041 |
|
|
2018
Q3 | $100K | Buy |
676
+253
| +60% | +$38.5K | 0.01% | 880 |
|
|
2018
Q2 | $65K | Hold |
423
| – | – | 0.01% | 930 |
|
|
2018
Q1 | $58K | Hold |
423
| – | – | 0.01% | 942 |
|
|
2017
Q4 | $57K | Buy |
423
+21
| +5% | +$2.77K | 0.01% | 944 |
|
|
2017
Q3 | $52K | Sell |
402
-17
| -4% | -$2.27K | 0.01% | 922 |
|
|
2017
Q2 | $55K | Sell |
419
-1
| -0.2% | -$122 | 0.01% | 885 |
|
|
2017
Q1 | $51K | Sell |
420
-161
| -28% | -$19.1K | 0.01% | 879 |
|
|
2016
Q4 | $64K | Hold |
581
| – | – | 0.01% | 743 |
|
|
2016
Q3 | $68K | Buy |
581
+162
| +39% | +$19.1K | 0.01% | 702 |
|
|
2016
Q2 | $47K | Hold |
419
| – | – | 0.01% | 826 |
|
|
2016
Q1 | $42K | Buy |
+419
| New | +$40.2K | 0.01% | 851 |
|
Other funds holding LH
VCM
VPM
Geneos Wealth Management's LH Position: Q1 2026 in Review
Geneos Wealth Management reduced its Labcorp (LH) stake by 4.7% in Q1 2026, selling an estimated $7.31K and leaving 550 shares worth $147K. The position accounts for ﹤0.01% of the portfolio, ranked #1062.
Geneos Wealth Management first reported a position in LH in Q1 2016 and has held it in 40 quarters since. The position peaked at $649K in Q1 2021. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.
- Geneos Wealth Management held 550 shares of Labcorp worth $147K as of Q1 2026.
- Geneos Wealth Management sold 27 Labcorp shares in Q1 2026, an estimated $7.31K.
- Labcorp made up ﹤0.01% of Geneos Wealth Management's portfolio in Q1 2026, its #1062 holding.
- Geneos Wealth Management first reported a position in Labcorp in Q1 2016 and has held it in 40 quarters since.
- Geneos Wealth Management's Labcorp position peaked at $649K in Q1 2021.
- 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.
Based on Geneos Wealth Management's 13F filing for Q1 2026, filed 5 May 2026.